Press / News Releases
Chengdu Frontier BioSciences of China Selects Pristima For Preclinical Data Management
Pristima Suite Is Key To Frontier’s Goal of Becoming Preeminent Preclinical Service Provider Read more »
Frontier BioSciences, Inc., (Frontier) has hired Joseph J. Stashick, RQAP-GLP as the new Director of Quality Assurance
Frontier is pleased to announce the addition of Joseph J. Stashick, RQAP-GLP as the new Director of Quality Assurance. Read more »
Frontier BioSciences Appoints Mark Walker a Senior Post at its China Facility
Frontier is pleased to announce the addition of Mark D. Walker, DVM as Vice President of Toxicology, Pathology, and Laboratory Animal Medicine. Read more »
WestChina-Frontier PharmaTech Awarded full AAALAC Accreditation
WestChina-Frontier PharmaTech , also known as the National Chengdu Center for Safety Evaluation of Drugs (NCCSED), received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International. AAALAC is an internationally recognized, not-for-profit organization, which promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Read more »
Frontier BioSciences, Inc. Signs Agreement with Top China-based Preclinical CRO
Frontier BioSciences, Inc. announced that it has signed a formal agreement with the National Chengdu Center for Safety Evaluation of Drugs (NCCSED) to become shareholder and strategic partner in the preclinical contract research service business. Read more »